Targeting cPLA2 derived lipid hydroperoxides as a potential intervention for sarcopenia

Gavin Pharaoh, Jacob L. Brown, Kavithalakshmi Sataranatarajan, Parker Kneis, Jan Bian, Rojina Ranjit, Niran Hadad, Constantin Georgescu, Peter Rabinovitch, Qitao Ran, Jonathan D. Wren, Willard Freeman, Michael Kinter, Arlan Richardson, Holly Van Remmen

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Defects in neuromuscular innervation contribute significantly to the age-related decline in muscle mass and function (sarcopenia). Our previous studies demonstrated that denervation induces muscle mitochondrial hydroperoxide production (H2O2 and lipid hydroperoxides (LOOHs)). Here we define the relative contribution of mitochondrial electron transport chain (ETC) derived H2O2 versus cytosolic phospholipase A2 (cPLA2) derived LOOHs in neurogenic muscle atrophy. We show that denervation increases muscle cPLA2 protein content, activity, and metabolites downstream of cPLA2 including LOOHs. Increased scavenging of mitochondrial H2O2 does not protect against denervation atrophy, suggesting ETC generated H2O2 is not a critical player. In contrast, inhibition of cPLA2 in vivo mitigates LOOH production and muscle atrophy and maintains individual muscle fiber size while decreasing oxidative damage. Overall, we show that loss of innervation in several muscle atrophy models including aging induces generation of LOOHs produced by arachidonic acid metabolism in the cPLA2 pathway contributing to loss of muscle mass.

Original languageEnglish (US)
Article number13968
JournalScientific reports
Issue number1
StatePublished - Dec 1 2020

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Targeting cPLA2 derived lipid hydroperoxides as a potential intervention for sarcopenia'. Together they form a unique fingerprint.

Cite this